Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?
Yohei Sotomi(Kyoto University), Takeshi Kimura(Municipal Hirakata City Hospital), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Yosuke Miyazaki(Yamaguchi University), Gregg W. Stone(Cardiovascular Institute of the South), Erhan Tenekecioğlu(Erasmus University Rotterdam), Taku Asano(Amsterdam UMC Location University of Amsterdam), Patrick W. Serruys(Erasmus MC), Hans Jonker(Cardialysis (Netherlands)), Jeffrey J. Popma(Cardiovascular Research Foundation), Ken Kozuma(Teikyo University Hospital), Kengo Tanabe, Yuki Katagiri(University of Amsterdam), Jouke Dijkstra(Leiden University), Robbert de Winter(Institute for Atherosclerosis Research), Joanna J. Wykrzykowska(University Medical Center Groningen)
Cited by 6
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
|New England Journal of Medicine|2010|3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k